Projects per year
Abstract
By the time cardiotoxicity-associated cardiac dysfunction is detectable by echocardiography it is often beyond meaningful intervention. 99mTc-sestamibi is used clinically to image cardiac perfusion by single photon emission computed tomography (SPECT) imaging, but as a lipophilic cation its distribution is also governed by mitochondrial membrane potential (ΔΨm). Correcting scans for variations in perfusion (using a ΔΨm-independent perfusion tracer such as (bis(N-ethoxy-N-ethyldithiocarbamato)nitrido 99mTc(V)) (99mTc-NOET) could allow 99mTc-sestamibi to be repurposed to specifically report on ΔΨm as a readout of evolving cardiotoxicity. Isolated rat hearts were perfused within a γ-detection apparatus to characterize the pharmacokinetics of 99mTc-sestamibi and 99mTc-NOET in response to mitochondrial perturbation by hypoxia, ionophore (CCCP) or doxorubicin. All interventions induced 99mTc-sestamibi washout; hypoxia from 24.9 ± 2.6% ID to 0.4 ± 6.2%, CCCP from 22.8 ± 2.5% ID to −3.5 ± 3.1%, and doxorubicin from 23.0 ± 2.2% ID to 17.8 ± 0.7, p
Original language | English |
---|---|
Article number | 216 |
Pages (from-to) | 216-227 |
Number of pages | 11 |
Journal | Scientific Reports |
Volume | 9 |
Early online date | 18 Jan 2019 |
DOIs | |
Publication status | Published - 2019 |
Fingerprint
Dive into the research topics of 'Detection of anthracycline-induced cardiotoxicity using perfusion-corrected 99mTc sestamibi SPECT'. Together they form a unique fingerprint.Projects
- 1 Finished
-
Development of new hypoxia-avid PET agents for the imaging of chronic cardiovascular disease
Southworth, R., Blower, P., Clark, J. & Eykyn, T.
1/01/2017 → 31/12/2019
Project: Research